Thyroid disease
Conditions
Interventions
In addition to regular medical care, the participants are collected their blood with an unapproved self-blood collection apparatus.
Sponsors
Yoshimura Hiroshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Those whose age is 21 or older. (Helthy volunteers, patients) 2. Those who come to Ito Hospital. (Patients) 3. Those who collected blood on the day of obtaining consent (Patients) 4. Those who can agree informed consent by their own intention. (Healthy volunteers, patients) 5. P.I. or contributor decide the sample as appropriate for this research. (patients)
Exclusion criteria
Exclusion criteria: 1. Those who come to Ito Hospital at first time. (Patients) 2. Those who have injured skin (broken, swollen, rash) on their upper arms. (Healthy volunteers, patients) 3. Those who have allergic to stainless steel. (Healthy volunteers, patients) 4. P.I. or contributor decide the sample as inappropriate for this research. (Healthy volunteers, patients)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Obtain patient samples with thyroid disease derived from venous blood and capillary blood taken by microneedle self-sampling device. The number of samples are equal to or greater than 50, including 7 patients who have high TSH value. Comparison of slope and correlation by Passing-Bablok method for both TSH and FreeT4. | — |
Secondary
| Measure | Time frame |
|---|---|
| Use same sample set used for TSH and FreeT4 measurements to measure the biomarkers for monitoring the side effect by thyroid disease treatment such as ALT, AST, Total bilirubin, and Creatinine. | — |
Contacts
Public ContactHiroshi Yoshimura
Ito hospital
Outcome results
None listed